CELL-BASED WOUND TX TO BE DEVELOPED

Article

An affiliate company of DFB Pharmaceuticals Inc, Healthpoint, Ltd., has signed an exclusive agreement with IsoTis, S.A. to develop and license its patented, biologic, wound-healing technology called Allox.

Related Videos
Related Content

Julie Harper, MD to Present a Rosacea Research Roundup and Pearls

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Make the Most of Your Visit to Asheville for Maui Derm NP + PA Fall 2023

September 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

Journal Digest: September 26

September 26th 2023

Julie Harper, MD to Present a Rosacea Research Roundup and Pearls

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Make the Most of Your Visit to Asheville for Maui Derm NP + PA Fall 2023

September 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

Journal Digest: September 26

September 26th 2023

Julie Harper, MD to Present a Rosacea Research Roundup and Pearls

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Make the Most of Your Visit to Asheville for Maui Derm NP + PA Fall 2023

September 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

Journal Digest: September 26

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.